Drugs / Amnion Chorion membrane
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT06508476 | Aug 2024 → Jan 2025 | gingival recession | Minia University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02679209 | Jun 2015 → May 2017 | chronic periodontitis | Cairo University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amnion chorion membrane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02679209 ↗ |
| Modality | Other / unclassified | “A bioresorbable allograft membrane for guided tissue regeneration from amnion and chorion parts of the placenta from pregnant females for guided tissue regeneration.” NCT02679209 ↗ |